Skip to main content

LIVE

BLTE

Belite Bio, Inc

BLTE

NASDAQ·Healthcare·Biotechnology·Mkt cap $7.8B

$193.61

+13.16%

P/E

-139.29

Mkt Cap

$7.8B

52-Wk Range

$64.80–$200.00

52-Week Range

$64.80 - $200.00

P/E

-139.29

Fwd P/E

-60.88

Beta

-1.24

Div Yield

0.00%

Avg Vol

194.9K

Shares Out

Mkt Cap

$7.8B

Price action

Price chart

Up 186.8% over the trailing year

Total returns

Price performance

Total return across standard periods - splits & dividends adjusted by FMP. Periods longer than 1Y show annualized in the tooltip.

Why we rate it this way

The thesis at a glance

Bull and bear case · plain-English context across the five lenses we evaluate.

Bull Case

No bull reasons captured for this rating yet.

Bear Case

1 risk

  • Low volatility (beta -1.2).

Growth

Stable outlook

Value

Deep value opportunity - significant discount to sector peers

Momentum

Hot

+38.7% over 3m

Quality

Loss-making

Solid business

Dividend

None

No dividend

Earnings track record

Recent earnings results

AI-summarized recap of last quarter, plus the surprise on every print.

Next: Nov 9, 2026

Q3 26 RECAP

AUG 12, 2026

Reported EPS of -$0.70 vs -$0.73 consensus (+4.1% surprise).

EPS beat +4.1%

EPS surprise · last 4Q

1 of 1 beats

Estimate

Actual

Q3 26

+4.1%

Revenue trend · last 2Q

Q1 26

Q2 26

$0

$0

Margins · last 2Q

No margin history available.

Wall Street consensus

3 analysts · 100% Buy

Live ratings and price targets aggregated across covering analysts.

Buy

3

100%

Hold

0%

Sell

0%

Median Price Target

Latest: Morgan Stanley · Aug 14, 2026

vs Industry

How BLTE stacks vs Biotechnology

Stock metrics vs industry averages. Green = better than industry.

Industry comparison data unavailable for this stock.